• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 08 May 2026

OPRT's 1Q:26 Results In Line With Expectations; Earnings Lower Due To Higher NCO, As Expected; 2026 Guidance Reaffirmed; Highlight Risk Based Pricing; Maintain $10 Price Target


Oportun Financial Corp (OPRT:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Brendan McCarthy

    • 10 pages


 

1Q:26 results were mostly in line with our expectations, with adjusted EPS of $0.07, as higher net charge offs (NCO) weighed on year over year comparisons. Still, the company delivered its sixth consecutive quarter of GAAP profitability and OPRT-direct EPS registered $0.21. OPRT reaffirmed 2026 guidance of adjusted EBITDA of $150-$165 million, up 6% at the midpoint. The company's adjusted EPS guidance of $1.50-$1.65 incorporates various exclusions and represents strong 16% growth at the midpoint; we estimate company-adjusted EPS of $1.54. Our 2026 EPS estimate (exludes fair value changes) is $1.13. New CEO Doug Bland, only a few weeks into the role, emphasized improving through-cycle credit performance to rebuild durable, profitable growth. Our 2026 estimates imply gradually improving credit performance and continued debt repayment driving 13% year over year growth in OPRT-adjusted EPS to $1.54 (guidance is $1.50-$1.65) and 7% growth in adjusted EBITDA to $159 million ($150-$165 million). We expect OPRT to maintain a conservative approach to underwriting, as credit should improve throughout 2026. After a 12.7% net charge off (NCO) rate in 1Q:26, we expect the rate to step down to the low-11% range to reach the 2026 NCO rate guidance of 11.9% (+/- 50 basis points). Balance sheet improvement remains a key growth driver. OPRT reduced interest expense by 16% year over year to $48 million in 1Q:26 on debt repayment. The company ended 1Q:26 with leverage of 6.8x (7.6x at 1Q:25). We maintain our $10 price target, based on an approximate 7x multiple applied to our 2027 adjusted EPS estimate of $1.54. Our moderate risk rating reflects the economic sensitivity of OPRT's borrowing cohort and its credit products.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

OPRT's 1Q:26 Results In Line With Expectations; Earnings Lower Due To Higher NCO, As Expected; 2026 Guidance Reaffirmed; Highlight Risk Based Pricing; Maintain $10 Price Target


Oportun Financial Corp (OPRT:NYSE) | 0 0 0.0%


  • Published: 08 May 2026
  • Author: Brendan McCarthy
  • Pages: 10
  • Sidoti & Company


1Q:26 results were mostly in line with our expectations, with adjusted EPS of $0.07, as higher net charge offs (NCO) weighed on year over year comparisons. Still, the company delivered its sixth consecutive quarter of GAAP profitability and OPRT-direct EPS registered $0.21. OPRT reaffirmed 2026 guidance of adjusted EBITDA of $150-$165 million, up 6% at the midpoint. The company's adjusted EPS guidance of $1.50-$1.65 incorporates various exclusions and represents strong 16% growth at the midpoint; we estimate company-adjusted EPS of $1.54. Our 2026 EPS estimate (exludes fair value changes) is $1.13. New CEO Doug Bland, only a few weeks into the role, emphasized improving through-cycle credit performance to rebuild durable, profitable growth. Our 2026 estimates imply gradually improving credit performance and continued debt repayment driving 13% year over year growth in OPRT-adjusted EPS to $1.54 (guidance is $1.50-$1.65) and 7% growth in adjusted EBITDA to $159 million ($150-$165 million). We expect OPRT to maintain a conservative approach to underwriting, as credit should improve throughout 2026. After a 12.7% net charge off (NCO) rate in 1Q:26, we expect the rate to step down to the low-11% range to reach the 2026 NCO rate guidance of 11.9% (+/- 50 basis points). Balance sheet improvement remains a key growth driver. OPRT reduced interest expense by 16% year over year to $48 million in 1Q:26 on debt repayment. The company ended 1Q:26 with leverage of 6.8x (7.6x at 1Q:25). We maintain our $10 price target, based on an approximate 7x multiple applied to our 2027 adjusted EPS estimate of $1.54. Our moderate risk rating reflects the economic sensitivity of OPRT's borrowing cohort and its credit products.

More Content

More Content

Sidoti Conference Takeaways: Outlook Backed By An Improved Balance Sheet And Selective Loan Growth; Risk-Based Pricing Slated To Launch In 2H:26; Maintain Estimates, $10 Price Target

Companies: Oportun Financial Corp

Sidoti & Company

OPRT: Initiate Coverage Of Oportun Financial With A $7 Price Tar

Companies: Oportun Financial Corp (OPRT:NYSE)Oportun Financial Corp. (OPRT:NAS)

Sidoti & Company

Highlight New CEO; Balance Sheet Optimization And Disciplined Originations Back Our 2026 Outlook; Expect Temporary Uptick In Charge-Offs In 1Q:26; Maintain Estimates, $10 Price Target

Companies: Oportun Financial Corp

Sidoti & Company

Note Investor Agreement; Remain Bullish On Fundamental Outlook; Forecast Expense Discipline Drove EPS Improvement In 2Q:25; Liquidity Position Remains Healthy; Maintain $10 Target

Companies: Oportun Financial Corp

Sidoti & Company

Sidoti Small Cap Conference Takeaways: Forecast Disciplined Approach To Growth In 2026 From Balance Sheet Optimization; Highlight Risk-Based Pricing Initiative; Maintain $10 Price Target

Companies: Oportun Financial Corp

Sidoti & Company
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2026

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Alternative Resource Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • Greenwood Capital Partners
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Primary Portal
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • RBC Capital Markets
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Investor Summit
      • The Life Sciences Division
      • ThinkFront
      • Ticker TV
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Venn Brown
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In